Korro Bio
Korro Bio is seeking a motivated Research Associate to join its Oligonucleotide Chemistry team, where the role involves synthesizing, purifying, and characterizing chemically modified oligonucleotides and conjugates on automated platforms. This hands-on, lab-based position requires practical experience in oligonucleotide synthesis, instrument operation, and maintaining meticulous records to support discovery programs. The successful candidate will collaborate cross-functionally and contribute to the development of transformative genetic medicines.
Korro Bio is a biotechnology company developing precision RNA‑editing therapeutics that edit a single letter on RNA to modulate biological pathways. Their mission is to translate this platform into genetic-medicine solutions for complex, prevalent diseases by advancing a focused therapeutic pipeline. The company emphasizes moving its science toward patient‑facing programs and resources (for example, work relevant to AATD) to deliver targeted, durable treatments.
Korro Bio Stock Gains After Tough 2025 - New Drug Candidate, Analyst Upgrades Boost Outlook
4 days ago
Korro Bio (KRRO) Losses Of US$117.3 Million Test Bullish Narratives On Profitability
4 days ago
JPM26: Korro Bio Looks To Save Itself Despite Unenviable Position
Jan 16, 2026
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Korro Bio.
Analysts Offer Insights on Healthcare Companies: Korro Bio (KRRO), Oruka Therapeutics (ORKA) and Gilead Sciences (GILD)
4 days ago
Research Associate II, Oligonucleotide Synthesis
CRISPR Therapeutics
Senior Scientist (Oligonucleotide Conjugation)
Amgen
Principal Research Associate - Oligonucleotide Chemistry
Alloy Therapeutics
Scientist I
Prime Medicine
Senior/Research Fellow, Oligonucleotide Chemistry [LKCMedicine]
Nanyang Technological University
Oligonucleotide Senior Scientist
Eurofins